Ligand validation:6YC3

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6YC3_LFA_C_313	39%	100%	0.159	0.866	0.07	0.04	-	-	1	0	100%	1
6YC3_LFA_E_314	19%	88%	0.195	0.93	0.23	0.44	-	-	0	0	20%	0.2
6YC3_LFA_D_311	17%	100%	0.198	0.777	0.07	0.05	-	-	0	0	100%	1
6YC3_LFA_A_313	17%	99%	0.199	0.904	0.14	0.1	-	-	0	0	30%	0.3
6YC3_LFA_E_313	15%	100%	0.191	0.804	0.08	0.05	-	-	0	0	70%	0.7
6YC3_LFA_D_310	14%	100%	0.209	0.754	0.08	0.03	-	-	0	0	100%	1
6YC3_LFA_E_315	12%	96%	0.215	0.881	0.15	0.22	-	-	0	0	25%	0.25
6YC3_LFA_C_312	9%	100%	0.212	0.802	0.1	0.07	-	-	0	0	40%	0.4
6YC3_LFA_B_309	7%	100%	0.207	0.775	0.11	0.06	-	-	0	0	40%	0.4
6YC3_LFA_B_310	5%	100%	0.191	0.698	0.1	0.07	-	-	0	0	50%	0.5
6YC3_LFA_A_310	5%	100%	0.204	0.727	0.11	0.08	-	-	0	0	40%	0.4
6YC3_LFA_C_314	5%	99%	0.217	0.758	0.13	0.1	-	-	0	0	30%	0.3
6YC3_LFA_A_312	5%	87%	0.25	0.8	0.24	0.44	-	-	0	0	20%	0.2
6YC3_LFA_D_313	5%	100%	0.416	0.849	0.07	0.07	-	-	3	0	85%	0.85
6YC3_LFA_D_312	4%	100%	0.198	0.693	0.11	0.07	-	-	0	0	40%	0.4
6YC3_LFA_B_311	4%	100%	0.233	0.735	0.11	0.08	-	-	0	0	35%	0.35
6YC3_LFA_A_311	4%	100%	0.252	0.723	0.1	0.07	-	-	0	0	40%	0.4
6YC3_LFA_D_314	4%	99%	0.201	0.678	0.12	0.08	-	-	0	0	35%	0.35
6YC3_LFA_A_309	3%	99%	0.27	0.742	0.12	0.08	-	-	0	0	35%	0.35
6YC3_LFA_C_315	3%	88%	0.312	0.787	0.24	0.42	-	-	0	0	20%	0.2
6YC3_LFA_A_314	3%	100%	0.378	0.738	0.08	0.06	-	-	0	0	80%	0.8
6YC3_LFA_B_308	2%	100%	0.385	0.796	0.11	0.07	-	-	2	0	45%	0.45
6YC3_LFA_E_312	2%	100%	0.233	0.612	0.1	0.07	-	-	0	0	40%	0.4
6YC3_LFA_A_319	2%	100%	0.342	0.677	0.11	0.07	-	-	0	0	45%	0.45
6YC3_LFA_C_311	1%	99%	0.367	0.663	0.13	0.07	-	-	4	0	35%	0.35
6YC3_LFA_D_315	1%	99%	0.301	0.518	0.13	0.11	-	-	0	0	30%	0.3
6YC3_LFA_A_318	0%	99%	0.924	0.674	0.12	0.1	-	-	0	0	100%	1
6YC3_LFA_B_302	0%	99%	0.942	0.667	0.12	0.09	-	-	0	0	100%	1
6YC3_LFA_D_301	0%	99%	0.982	0.689	0.12	0.11	-	-	1	0	100%	1
6YC3_LFA_C_304	0%	100%	1.008	0.712	0.1	0.09	-	-	2	0	100%	1
6YC3_LFA_E_303	0%	99%	1.024	0.67	0.13	0.1	-	-	0	0	100%	1
6YC3_LFA_B_314	0%	88%	1.796	0.884	0.23	0.44	-	-	3	0	20%	0.2
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	0.7
4XTL_LFA_A_315	46%	89%	0.079	0.949	0.26	0.38	-	-	1	0	25%	0.25
4XTN_LFA_J_311	43%	74%	0.092	0.958	0.38	0.61	-	-	1	0	20%	0.2
6XYT_LFA_C_309	41%	100%	0.165	0.878	0.07	0.05	-	-	0	0	100%	1
6RFC_LFA_A_336	39%	87%	0.105	0.92	0.24	0.46	-	-	0	0	40%	0.4
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	5	0	75%	0.75
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	0.55
8R98_LFA_A_401	55%	100%	0.089	0.937	0.09	0.08	-	-	0	0	55%	0.55
7Z09_LFA_A_801	40%	76%	0.087	0.914	0.37	0.58	-	-	1	0	35%	0.35

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.